A pharmaceutical company developing drugs for autoimmune/metabolic and neurological diseases, with a special focus on the needs of individuals with Down syndrome.
LATEST NEWS
Jun 22, 2018
Pharmasum is gearing up to enter clinical studies in Down syndrome READ MORE >>
May 23, 2018
Meet Pharmasum Therapeutics at the annual BIO meeting, Boston, USA READ MORE >>
Nov 13, 2017
Pharmasum participated in round-table discussions and gave a presentation at World HealthEx Forum and Inv€stival Showcase, in London, UK READ MORE >>